Business Description
Kraig Biocraft Laboratories Inc
NAICS : 325180
SIC : 2819
ISIN : US50075W1045
Total Employee Number:
14Description
Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fiber using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; Dragon Silk, which combines the elasticity of Monster Silk with additional high-strength elements of native spider silk; Spydasilk; and Spydra.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.75 | |||||
Equity-to-Asset | -1.9 | |||||
Debt-to-Equity | -0.23 | |||||
Debt-to-EBITDA | -0.49 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 56.97 | |||||
9-Day RSI | 49.78 | |||||
14-Day RSI | 45.93 | |||||
3-1 Month Momentum % | -31.82 | |||||
6-1 Month Momentum % | 25.78 | |||||
12-1 Month Momentum % | 24.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.28 | |||||
Quick Ratio | 0.27 | |||||
Cash Ratio | 0.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.7 | |||||
Shareholder Yield % | -4.18 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -171.7 | |||||
ROIC % | -154.14 | |||||
3-Year ROIIC % | 1279.59 | |||||
ROC (Joel Greenblatt) % | -2098.51 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | -32.63 | |||||
EV-to-EBITDA | -32.88 | |||||
EV-to-FCF | -58.23 | |||||
Earnings Yield (Greenblatt) % | -3.06 | |||||
FCF Yield % | -1.78 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KBLB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kraig Biocraft Laboratories Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | 2.0874 | ||
| 3-Year Sharpe Ratio | 0.58 | ||
| 3-Year Sortino Ratio | 2.09 | ||
| Volatility % | 93.07 | ||
| 14-Day RSI | 45.93 | ||
| 14-Day ATR ($) | 0.007918 | ||
| 20-Day SMA ($) | 0.097655 | ||
| 12-1 Month Momentum % | 24.24 | ||
| 52-Week Range ($) | 0.0716 - 0.16 | ||
| Shares Outstanding (Mil) | 1,113.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kraig Biocraft Laboratories Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kraig Biocraft Laboratories Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-12 | In 102 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 12 days | ||
| General meeting for 2025 | 2026-08-03 | In 1 day | ||
| First quarter earnings results for 2026 | 2026-05-14 | 0.14 (-0.28%) | ||
| Annual report for 2025 | 2026-03-30 | 0.12 (-1.08%) | ||
| Third quarter earnings results for 2025 | 2025-11-12 | 0.09 (+2.53%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 0.08 (+0.86%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 0.09 (-3.78%) | ||
| Annual report for 2024 | 2025-03-28 | 0.08 (-0.37%) | ||
| Investor web conference | 2024-12-04 16:30 | 0.09 (-0.10%) |
Show
Entries
Kraig Biocraft Laboratories Inc Frequently Asked Questions
What is Kraig Biocraft Laboratories Inc(KBLB)'s stock price today?
The current price of KBLB is $0.10. The 52 week high of KBLB is $0.16 and 52 week low is $0.07.
When is next earnings date of Kraig Biocraft Laboratories Inc(KBLB)?
The next earnings date of Kraig Biocraft Laboratories Inc(KBLB) is 2026-08-14 Est..
Does Kraig Biocraft Laboratories Inc(KBLB) pay dividends? If so, how much?
Kraig Biocraft Laboratories Inc(KBLB) does not pay dividend.
Guru Commentaries on OTCPK:KBLB
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kraig Biocraft Laboratories Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers